Comments
Loading...

LeMaitre Vascular

LMATNASDAQ
Logo brought to you by Benzinga Data
$97.23
-3.89-3.85%
At close: -
$97.23
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$100.00
Lowest Price Target1
$67.00
Consensus Price Target1
$87.38

LeMaitre Vascular (NASDAQ:LMAT) Stock, Analyst Ratings, Price Targets, Forecasts

LeMaitre Vascular Inc has a consensus price target of $87.38 based on the ratings of 9 analysts. The high is $100 issued by JMP Securities on August 20, 2024. The low is $67 issued by Jefferies on August 3, 2023. The 3 most-recent analyst ratings were released by Oppenheimer, Barrington Research, and Cantor Fitzgerald on November 1, 2024, November 1, 2024, and October 15, 2024, respectively. With an average price target of $94 between Oppenheimer, Barrington Research, and Cantor Fitzgerald, there's an implied -3.32% downside for LeMaitre Vascular Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Aug
1
Sep
1
Oct
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
Barrington Research
Cantor Fitzgerald
JMP Securities
Roth MKM

1calculated from analyst ratings

Analyst Ratings for LeMaitre Vascular

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for LeMaitre Vascular (LMAT) stock?

A

The latest price target for LeMaitre Vascular (NASDAQ:LMAT) was reported by Oppenheimer on November 1, 2024. The analyst firm set a price target for $93.00 expecting LMAT to fall to within 12 months (a possible -4.35% downside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for LeMaitre Vascular (LMAT)?

A

The latest analyst rating for LeMaitre Vascular (NASDAQ:LMAT) was provided by Oppenheimer, and LeMaitre Vascular reiterated their outperform rating.

Q

When was the last upgrade for LeMaitre Vascular (LMAT)?

A

The last upgrade for LeMaitre Vascular Inc happened on April 26, 2024 when Stifel raised their price target to $75. Stifel previously had a hold for LeMaitre Vascular Inc.

Q

When was the last downgrade for LeMaitre Vascular (LMAT)?

A

The last downgrade for LeMaitre Vascular Inc happened on August 3, 2023 when Jefferies changed their price target from $63 to $67 for LeMaitre Vascular Inc.

Q

When is the next analyst rating going to be posted or updated for LeMaitre Vascular (LMAT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LeMaitre Vascular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LeMaitre Vascular was filed on November 1, 2024 so you should expect the next rating to be made available sometime around November 1, 2025.

Q

Is the Analyst Rating LeMaitre Vascular (LMAT) correct?

A

While ratings are subjective and will change, the latest LeMaitre Vascular (LMAT) rating was a reiterated with a price target of $90.00 to $93.00. The current price LeMaitre Vascular (LMAT) is trading at is $97.23, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch